Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Viral hepatitis C]

S Zeuzem1, W K Roth, G Herrmann

  • 1Medizinische Klinik II, Johann Wolfgang Goethe-Universität Frankfurt a.M..

Zeitschrift Fur Gastroenterologie
|February 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Rituximab therapy for relapsing IgG4-autoimmune pancreatitis and cholangitis - a case report].

Zeitschrift fur Gastroenterologie·2015
Same author

[Rapid-progressive decrease of cognitive and physical functions in a B-cell non-Hodgkin's lymphoma patient treated with rituximab/bendamustine].

Deutsche medizinische Wochenschrift (1946)·2013
Same author

Placement of coiled catheters into the paravertebral space.

Anaesthesia·2012
Same author

Ultrasound-guided thoracic paravertebral puncture and placement of catheters in human cadavers: where do catheters go?

British journal of anaesthesia·2010
Same author

Hydrodissection for subperichondrial septoplasty - an experimental anatomical study.

Rhinology·2010
Same author

Clinical value of sentinel node mapping in carcinoma of the colon.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2010
Same journal

[Version 7.0 of the S3 Guideline on Ulcerative Colitis sets out clearly defined treatment goals, an open treatment sequence, and a call for improved cross-sectoral care].

Zeitschrift fur Gastroenterologie·2026
Same journal

Zeitschrift fur Gastroenterologie·2026
Same journal

Zeitschrift fur Gastroenterologie·2026
Same journal

[Updated S3 guideline on ulcerative colitis].

Zeitschrift fur Gastroenterologie·2026
Same journal

Zeitschrift fur Gastroenterologie·2026
Same journal

Zeitschrift fur Gastroenterologie·2026
See all related articles

Hepatitis C virus (HCV) infection is a major cause of liver disease. While interferon-alpha shows some efficacy, its sustained response rate is low, and vaccine development is challenging due to viral genetic diversity.

Area of Science:

  • Virology: Focus on the (+)stranded RNA hepatitis C virus (HCV).
  • Immunology: Examination of immune-mediated cytotoxicity in HCV infection.

Context:

  • Hepatitis C virus (HCV) identified as the primary cause of non-A, non-B hepatitis.
  • Recent investigations into HCV's genomic structure, genotypes, and replication sites (hepatic and extrahepatic).
  • HCV exhibits significant genetic heterogeneity and rapid mutation, forming quasispecies and neutralization escape mutants.

Purpose:

  • To review fundamental, diagnostic, and clinical aspects of acute and chronic HCV infection.
  • To discuss HCV's association with other diseases and complications like liver cirrhosis and hepatocellular carcinoma.
  • To evaluate the efficacy and limitations of interferon-alpha therapy and discuss post-transplant HCV reinfection.

Summary:

  • Interferon-alpha normalizes aminotransferases and reduces liver inflammation in approximately 50% of chronic hepatitis C patients, but sustained response rates are below 30% post-treatment.

Related Experiment Videos

  • HCV reinfection is common after liver transplantation, though typically mild under immunosuppression.
  • Screening has reduced post-transfusion hepatitis C, but community-acquired transmission requires further study.

    • Impact:

    • Highlights challenges in achieving sustained virological response with current interferon-alpha treatments for chronic hepatitis C.
    • Underscores the difficulty in developing an effective hepatitis C vaccine due to the virus's rapid mutation and genetic diversity.
    • Emphasizes the need for continued research into HCV transmission and improved therapeutic strategies.